Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.
about
Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and ProgressionSteroid Hormone Receptor Signals as Prognosticators for Urothelial TumorInvolvement of the Androgen and Glucocorticoid Receptors in Bladder CancerConditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in MiceGATA3 in the urinary bladder: suppression of neoplastic transformation and down-regulation by androgensEstrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo.Chemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic miceAndrogen deprivation therapy prevents bladder cancer recurrenceModelling bladder cancer in mice: opportunities and challenges.Is there a gender effect in bladder cancer? A population-based study of practice and outcomesThe effects of early versus delayed castration targeting androgen on prolonging survival in a mouse model of bladder cancerTP53 modulating agent, CP-31398 enhances antitumor effects of ODC inhibitor in mouse model of urinary bladder transitional cell carcinoma.Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signalsAntiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression.Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals.Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo.Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrenceCollaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think Tank.Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer.AR-Signaling in Human Malignancies: Prostate Cancer and Beyond.Androgen Receptor Signaling in Bladder Cancer.High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer.Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals.Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals.Transgenic Mouse Models of SV40-Induced Cancer.Androgen receptor activation: a prospective therapeutic target for bladder cancer?Bladder cancers arise from distinct urothelial sub-populations.Enzalutamide as an androgen receptor inhibitor prevents urothelial tumorigenesis.Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice.Urinary Bladder Cancer in Egypt: Are There Gender Differences in Its Histopathological Presentation?X chromosome protects against bladder cancer in females via a KDM6A-dependent epigenetic mechanism.Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer
P2860
Q26744754-1C86799D-8897-4E95-B5DF-52CE857CB5B2Q26771960-832957BE-1C24-4DD5-A854-475A8FD04965Q26782760-47D6219D-912A-4D7E-A5B3-40909965F616Q28550059-397C83D6-3E30-4439-8082-E7430F92F78BQ34178465-EE7C7E28-C128-4F02-83A2-F18CBF4A5922Q34365942-34AEEA96-04A0-4B27-BC00-7BF89EC43573Q35027361-8C6D38F4-8C34-4A47-B5CB-8FCE5EFDB1A6Q35149647-44F59E97-3E3E-4689-BE4A-7052F6766839Q35285703-41FE5168-6111-4102-88A3-ACF04FA26E4AQ35956254-51BD02F0-0F33-4480-B4B8-B5AE4A982DE6Q36261347-69F10C67-1EED-4218-BB42-FEA86B0F77BBQ36309384-47AE90AB-CD85-40A3-8D0B-FAACBA946076Q36413361-3C1A24BC-7DE9-482A-ACCB-ED54809EE8B8Q36439816-28347BBC-7193-4BDA-A94B-0D561363E0DEQ36619126-7BB74DCF-C300-4EB2-85BD-BB6539724D9EQ36820882-DBD04388-56CA-4913-9D0E-6CE948D5AB10Q37046554-84315F84-64D9-47BF-9616-80F3F0D41361Q37053881-14F274A7-3D63-4794-AFA7-F656AF44270FQ37580192-98E6BC3E-DD9E-445F-9E59-A0F8688745ACQ37589142-237639BA-476A-4A37-9DC1-B6AADD09E64BQ37629545-5B672955-792E-43B3-8A9B-E6159C449037Q37676080-C817FD55-0C39-4E08-A768-9F9C616671CEQ37723023-2574C904-19BE-49C0-A2D8-D0C3825DBEEEQ38729911-67954623-171A-43A9-9BA5-538433B38D27Q38769921-B7DA19C1-D092-4D6C-87BF-F7419D841B2DQ38795316-356EAB43-D1AE-4D50-84F7-6DCC082D4690Q39033724-9CAAD5B0-C6AB-4407-BED2-75E645A14D80Q42465565-A477ED1E-51A9-4E5C-9ACE-CA0989FC31F8Q46808504-4FC936FF-5964-40E7-BFB6-B108361B5EF3Q47559300-696C4516-7158-4750-AC24-F3FCB0E29094Q54221424-77BB5852-6873-49C7-9C6A-233A0160BEEEQ55306154-443A1C8E-2F05-43F5-B6E3-B58651C33186Q58705140-6B5719E4-0375-4BFE-B308-0C8D2D88408E
P2860
Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Decreased tumorigenesis and mo ...... urothelial androgen receptor.
@ast
Decreased tumorigenesis and mo ...... urothelial androgen receptor.
@en
type
label
Decreased tumorigenesis and mo ...... urothelial androgen receptor.
@ast
Decreased tumorigenesis and mo ...... urothelial androgen receptor.
@en
prefLabel
Decreased tumorigenesis and mo ...... urothelial androgen receptor.
@ast
Decreased tumorigenesis and mo ...... urothelial androgen receptor.
@en
P2093
P2860
P1476
Decreased tumorigenesis and mo ...... g urothelial androgen receptor
@en
P2093
Chawnshang Chang
Chih-Rong Shyr
Jong-Wei Hsu
Liang Liang
P2860
P304
P356
10.1016/J.AJPATH.2013.01.018
P407
P577
2013-03-13T00:00:00Z